Organic Active Ingredients TRIZ Cases

Specific benzothiadiazepine derivatives optimize potency and selectivity to overcome limited bioavailability in current bile acid modulators.

Assay overcomes catalytic subunit promiscuity by targeting regulatory subunits, enabling discovery of selective allosteric inhibitors.

A slime hydrogel formulation adheres to curved tooth surfaces and interproximal spaces using hydrogen bonding mechanisms.

A preparation method produces N-formyl vortioxetine reference standards for pharmaceutical quality control.

Substituted pyridone compounds bind influenza nucleoprotein to block ribonucleoprotein assembly, addressing resistance against existing antivirals.

Developing specific ferric maltol crystal forms resolves the trade-off between manufacturing ease and therapeutic reliability.

Acrylic adhesive dissolves free ropinirole, preventing metal salt precipitation and skin irritation.

Selective precipitation of iron, nickel, and copper complexes reduces total impurities below 0.5% without chromatographic yield loss.

Alkali treatment and cake filtration produce high-molecular-weight arabinoxylans that modulate intestinal microbial communities.

Azide-modified biomolecules inhibit viral infectivity and label viral proteins, reducing toxicity associated with existing anti-viral treatments.

Modular chemical structures with specific substituents overcome resistance mechanisms by selectively inhibiting BCL6 corepressor interactions.

Immunohistochemical staining identifies elevated PDGFR-α expression to predict metastatic potential and reduce recurrence rates in papillary thyroid cancer.

Segmented barrier walls and a nested bell element reduce installation height while preserving reliable wastewater flow for flat floor-level showers.

Derivatizing the amine group of 2-((2-ethoxyphenoxy)methyl)morpholine reduces side effects while preserving chemical stability.

Compound A targets hyper-proliferative diseases via selective ATR kinase inhibition.

Cyclic dinucleotide compounds stimulate pattern recognition receptors to activate innate immunity.

A p38 MAPK inhibitor reduces cytokine production to mitigate endotoxin-mediated inflammatory responses in horses.

Microfluidization reduces poorly soluble drug particles to the nanometer range, increasing dissolution rates and bioavailability without surfactant additives.

Esterified amino acid linkers at the C14 position reduce toxicity while maintaining anti-tumor efficacy.

High-concentration defibrotide formulations reduce liquid volume and dosing frequency, enabling convenient outpatient treatment.

Granular capsule fill combines hydrophilic polymers and organic acids to deter abuse while ensuring immediate API release.

PTEN and SLC6A4 biomarkers enable accurate diagnosis of autism cases with increased head size, guiding targeted 5-HT2c receptor antagonist therapy.

Endogenous catalase polymerizes dopamine into a polydopamine layer on small intestinal mucosa.

Merges bevacizumab with anti-inflammatory agents to suppress VEGF-driven angiogenesis, preventing pterygium recurrence after surgical removal.

Introducing specific desaturases and elongases boosts vitamin E levels while resolving the trade-off between genetic complexity and production efficiency.

Targeting the BTK variant overcomes trastuzumab resistance and improves treatment effectiveness by sensitizing cells to chemotherapeutic agents.

Deuterated elacridar analogs modify metabolic stability to improve bioavailability and plasma half-life.

Dual inhibitors block VEGF and HGF receptors to prevent tumor invasion and metastasis.

Solubilized estradiol in a soft gel insert maintains therapeutic concentration and lowers vaginal pH to treat atrophy symptoms.

VCP inhibitors sensitize resistant tumors to oncolytic virus therapy, reducing cell survival rates without increasing systemic toxicity.

A PKC activator induces selective class switching in B cells from IgE to IgA production.

Amphiphilic prodrugs self-assemble into nanofiber hydrogels for sustained local drug release.

Segmented DSPC and DPPC liposomes prolong cisplatin half-life, reducing systemic toxicity while maintaining synergistic antitumor activity.

Indazole compounds antagonize Wnt pathway activity to correct genetic disorders and treat cancers.

Azetidinyl methanone derivatives inhibit MEK kinase activity to treat proliferative diseases.

A flexible magnetic film drives aggrecan precursors through the skin barrier using diamagnetic repulsion to enhance transdermal penetration.

Naringenin regulates immune-related cytokines to ameliorate radiation-induced lung injury and prolong survival in tumor-bearing mice.

Oral branched chain amino acids rebalance excitatory synaptic activity to mitigate cognitive and sleep impairments caused by traumatic brain injury.